DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $150,000 | -52.7% | 7,465 | -12.1% | 0.00% | -50.0% |
| Q2 2021 | $317,000 | +66.0% | 8,497 | +13.8% | 0.00% | +100.0% |
| Q1 2021 | $191,000 | -1.0% | 7,465 | -14.6% | 0.00% | 0.0% |
| Q4 2020 | $193,000 | +52.0% | 8,744 | +24.1% | 0.00% | 0.0% |
| Q3 2020 | $127,000 | -29.1% | 7,046 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $179,000 | +118.3% | 7,046 | +56.9% | 0.00% | +100.0% |
| Q1 2020 | $82,000 | +10.8% | 4,491 | +33.5% | 0.00% | 0.0% |
| Q4 2019 | $74,000 | +54.2% | 3,363 | 0.0% | 0.00% | – |
| Q3 2019 | $48,000 | +37.1% | 3,363 | +52.0% | 0.00% | – |
| Q2 2019 | $35,000 | +9.4% | 2,212 | 0.0% | 0.00% | – |
| Q1 2019 | $32,000 | -13.5% | 2,212 | -36.1% | 0.00% | – |
| Q4 2018 | $37,000 | +311.1% | 3,459 | +512.2% | 0.00% | – |
| Q3 2018 | $9,000 | – | 565 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |